1. A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial. Issue 8 (August 2022) Authors: Watanabe, Genki; Mise, Yoshihiro; Oba, Masaru; Saiura, Akio; Inoue, Yosuke; Takahashi, Yu; Kishi, Yoji; Suyama, Koichi; Takayama, Tadatoshi; Noie, Tamaki; Nishioka, Yujiro; Akamatsu, Nobuhisa; Arita, Junichi; Kokudo, Norihiro; Hasegawa, Kiyoshi Journal: HPB Issue: Volume 24:Issue 8(2022) Page Start: 1245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗